Nouveaux composés
- 专利权人:
- Novartis AG
- 发明人:
- 申请号：
- EP11158212.8
- 公开号：
- EP2404905A1
- 申请日:
- 2007.03.28
- 申请国别(地区):
- EP
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention provides new organic compounds that are useful in the treatment of conditions or disorders associated with DGAT1 activity, particularly type 2 diabetes, and pharmaceutical compositions and combinations comprising such compounds.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Heterocyclic gpr119 agonist compounds
- NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE
- A NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE
- NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE
- Pharmaceutical compound and composition for use in treating type II diabetes comprising rosiglitazone in a specific particle size
